{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T20:44:55Z","timestamp":1785012295863,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Development Project of Jilin Province","award":["20210401174YY"],"award-info":[{"award-number":["20210401174YY"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89535-7","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T09:30:08Z","timestamp":1739439008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation"],"prefix":"10.1038","volume":"15","author":[{"given":"Ruiqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9159-2747","authenticated-orcid":false,"given":"Wenlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"89535_CR1","doi-asserted-by":"crossref","unstructured":"Rajkumar, S. V. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am. J. Hematol. (2024).","DOI":"10.1002\/ajh.27422"},{"key":"89535_CR2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.4065\/83.10.1131","volume":"83","author":"MA Gertz","year":"2008","unstructured":"Gertz, M. A. et al. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative. Mayo Clin. Proc. 83, 1131\u20131138 (2008).","journal-title":"Mayo Clin. Proc."},{"key":"89535_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1600-0609.2005.00605.x","volume":"76","author":"E Jantunen","year":"2006","unstructured":"Jantunen, E. et al. Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur. J. Haematol. 76, 245\u2013250 (2006).","journal-title":"Eur. J. Haematol."},{"key":"89535_CR4","doi-asserted-by":"publisher","first-page":"7641","DOI":"10.1002\/cam4.4294","volume":"10","author":"J Gu","year":"2021","unstructured":"Gu, J. et al. Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma. Cancer Med. 10, 7641\u20137649 (2021).","journal-title":"Cancer Med."},{"key":"89535_CR5","doi-asserted-by":"publisher","first-page":"103972","DOI":"10.1016\/j.transci.2024.103972","volume":"63","author":"X Qiu","year":"2024","unstructured":"Qiu, X. et al. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma. Transfus. Apher. Sci. 63, 103972 (2024).","journal-title":"Transfus. Apher. Sci."},{"key":"89535_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419","volume":"86","author":"K Kaushansky","year":"1995","unstructured":"Kaushansky, K. Thrombopoietin: the primary regulator of platelet production. Blood 86, 419\u2013431 (1995).","journal-title":"Blood"},{"key":"89535_CR7","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/ajh.25989","volume":"95","author":"Y Yu","year":"2020","unstructured":"Yu, Y. et al. High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: a prospective, multicenter, randomized trial. Am. J. Hematol. 95, 1542\u20131552 (2020).","journal-title":"Am. J. Hematol."},{"key":"89535_CR8","doi-asserted-by":"publisher","first-page":"e33373","DOI":"10.1097\/MD.0000000000033373","volume":"102","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Recombinant human thrombopoietin promotes platelet recovery in DCAG-treated patients with intermediate-high-risk MDS\/hypoproliferative AML. Medicine (Baltimore) 102, e33373 (2023).","journal-title":"Medicine (Baltimore)"},{"key":"89535_CR9","doi-asserted-by":"publisher","first-page":"2298523","DOI":"10.1080\/16078454.2023.2298523","volume":"29","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study. Hematology 29, 2298523 (2024).","journal-title":"Hematology"},{"key":"89535_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0037-1963(00)90050-7","volume":"37","author":"S Vadhan-Raj","year":"2000","unstructured":"Vadhan-Raj, S. Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia. Semin Hematol. 37, 28\u201334 (2000).","journal-title":"Semin Hematol."},{"key":"89535_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1186\/s12884-023-06134-y","volume":"23","author":"J Lin","year":"2023","unstructured":"Lin, J. et al. Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study. BMC Pregnancy Childbirth. 23, 820 (2023).","journal-title":"BMC Pregnancy Childbirth"},{"key":"89535_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/sj.bmt.1702772","volume":"27","author":"SN Wolff","year":"2001","unstructured":"Wolff, S. N. et al. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study. Bone Marrow Transpl. 27, 261\u2013268 (2001).","journal-title":"Bone Marrow Transpl."},{"key":"89535_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1083-8791(00)70049-8","volume":"6","author":"RA Nash","year":"2000","unstructured":"Nash, R. A. et al. A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. Biol. Blood Marrow Transpl. 6, 25\u201334 (2000).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"89535_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jtct.2024.02.023","volume":"30","author":"A Fu","year":"2024","unstructured":"Fu, A. et al. Recombinant human thrombopoietin promotes platelet engraftment in severe aplastic anemia patients following treatment with haploid hematopoietic stem cell transplantation using modified post-transplantation cyclophosphamide. Transpl. Cell. Ther. 30, 500\u2013509 (2024).","journal-title":"Transpl. Cell. Ther."},{"key":"89535_CR15","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2020002257","volume":"4","author":"B Tang","year":"2020","unstructured":"Tang, B. et al. Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation. Blood Adv. 4, 3829\u20133839 (2020).","journal-title":"Blood Adv."},{"key":"89535_CR16","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.bbmt.2017.06.010","volume":"23","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Recombinant human thrombopoietin promotes platelet engraftment and improves prognosis of patients with myelodysplastic syndromes and aplastic anemia after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transpl. 23, 1678\u20131684 (2017).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"89535_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00277-014-2158-1","volume":"94","author":"TT Han","year":"2015","unstructured":"Han, T. T. et al. Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial. Ann. Hematol. 94, 117\u2013128 (2015).","journal-title":"Ann. Hematol."},{"key":"89535_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/hon.3017","volume":"40","author":"B Wen","year":"2022","unstructured":"Wen, B. et al. Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: a prospective, non-inferiority, randomized controlled trial. Hematol. Oncol. 40, 777\u2013786 (2022).","journal-title":"Hematol. Oncol."},{"key":"89535_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12885-023-10907-1","volume":"23","author":"CM Lin","year":"2023","unstructured":"Lin, C. M. et al. Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis. BMC Cancer. 23, 446 (2023).","journal-title":"BMC Cancer"},{"key":"89535_CR20","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1097\/MPH.0000000000001340","volume":"41","author":"V Wiegering","year":"2019","unstructured":"Wiegering, V. et al. Comparison of immune reconstitution after allogeneic versus autologous stem cell transplantation in 182 pediatric recipients. J. Pediatr. Hematol. Oncol. 41, e302\u2013e307 (2019).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"89535_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2141.2006.06244.x","volume":"135","author":"W Schwinger","year":"2006","unstructured":"Schwinger, W. et al. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children. Br. J. Haematol. 135, 76\u201384 (2006).","journal-title":"Br. J. Haematol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89535-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89535-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89535-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T09:30:14Z","timestamp":1739439014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89535-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89535"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89535-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4933117\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5393"}}